Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CD21' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 113 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zabel, MD; Weis, JH
      Cell-specific regulation of the CD21 gene

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Boackle, SA; Holers, VM; Chen, XJ; Szakonyi, G; Karp, DR; Wakeland, EK; Morel, L
      Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein

      IMMUNITY
    3. Bagdi, E; Krenacs, L; Krenacs, T; Miller, K; Isaacson, PG
      Follicular dendritic cells in reactive and neoplastic lymphoid tissues: A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    4. Cheng, PC; Cherukuri, A; Dykstra, M; Malapati, S; Sproul, T; Chen, MR; Pierce, SK
      Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function

      SEMINARS IN IMMUNOLOGY
    5. Makar, KW; Ulgiati, D; Hagman, J; Holers, VM
      A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation

      INTERNATIONAL IMMUNOLOGY
    6. Abu El-Asrar, AM; Fatani, RA; Missotten, L; Geboes, K
      Expression of CD23/CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis

      EYE
    7. Schwab, J; Illges, H
      Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island

      RHEUMATOLOGY INTERNATIONAL
    8. Boersma, WJA; Zwart, RJ; Sinkora, J; Rehakova, Z; Haverson, K; Bianchi, ATJ
      Summary of workshop findings for porcine B-cell markers

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    9. de Leval, L; Harris, NL; Longtine, J; Ferry, JA; Duncan, LM
      Cutaneous B-cell lymphomas of follicular and marginal zone types - Use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    10. Murthy, KHM; Smith, SA; Ganesh, VK; Judge, KW; Mullin, N; Barlow, PN; Ogata, CM; Kotwal, GJ
      Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

      CELL
    11. Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS
      Structure of complement receptor 2 in complex with its C3d ligand

      SCIENCE
    12. Ulgiati, D; Holers, VM
      CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor

      JOURNAL OF IMMUNOLOGY
    13. Guthridge, JM; Young, K; Gipson, MG; Sarrias, MR; Szakonyi, G; Chen, XJS; Malaspina, A; Donoghue, E; James, JA; Lambris, JD; Moir, SA; Perkins, SJ; Holers, VM
      Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: Identification of a highly inhibitory monoclonalantibody that directly recognizes the CR2-C3d interface

      JOURNAL OF IMMUNOLOGY
    14. Vereshchagina, LA; Tolnay, M; Tsokos, GC
      Multiple transcription factors regulate the inducible expression of the human complement receptor 2 promoter

      JOURNAL OF IMMUNOLOGY
    15. Fakher, M; Wu, JH; Qin, DH; Szakal, AK; Tew, JG
      Follicular dendritic cell accessory activity crosses MHC and species barriers

      EUROPEAN JOURNAL OF IMMUNOLOGY
    16. Goodlad, JR
      Spindle-cell B-cell lymphoma presenting in the skin

      BRITISH JOURNAL OF DERMATOLOGY
    17. Guthridge, JM; Rakstang, JK; Young, KA; Hinshelwood, J; Aslam, M; Robertson, A; Gipson, MG; Sarrias, MR; Moore, WT; Meagher, M; Karp, D; Lambris, JD; Perkins, SJ; Holers, VM
      Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg

      BIOCHEMISTRY
    18. Kadoi, K
      Establishment of a canine monocyte cell line

      MICROBIOLOGICA
    19. Tolnay, M; Tsokos, GC
      Serum regulates the expression of complement receptor 2 on human B cell lines.

      IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
    20. Lopez-Matas, M; Rodrigue-Justo, M; Morilla, R; Catovsky, D; Matutes, E
      Quantitative expression of CD23 and its ligand CD21 in chronic lymphocyticleukemia

      HAEMATOLOGICA
    21. Barbera-Guillem, E; Nelson, MB; Barr, B; Nyhus, JK; May, KF; Feng, L; Sampsel, JW
      B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    22. Delibrias, CC; Fischer, EM; Kazatchkine, MD
      The enhancing role of complement in human immunodeficiency virus infection: Soluble recombinant CR1 (CD35) inhibits complement-mediated enhancement of infection of a CD4-positive T-cell line with human immunodeficiency virus-1

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    23. Pauwels, P; Dal Cin, P; Vlasveld, LT; Aleva, RM; van Erp, WFM; Jones, D
      A chromosomal abnormality in hyaline vascular Castleman's disease - Evidence for clonal proliferation of dysplastic stromal cells

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    24. Savard, M; Belanger, C; Tardif, M; Gourde, P; Flamand, L; Gosselin, J
      Infection of primary human monocytes by Epstein-Barr virus

      JOURNAL OF VIROLOGY
    25. D'Addario, M; Ahmad, A; Morgan, A; Menezes, J
      Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappa B involving PKC, P13-K and tyrosine kinases

      JOURNAL OF MOLECULAR BIOLOGY
    26. Moir, S; Malaspina, A; Li, YX; Chun, TW; Lowe, T; Adelsberger, J; Baseler, M; Ehler, LA; Liu, SY; Davey, RT; Mican, JAM; Fauci, AS
      B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells

      JOURNAL OF EXPERIMENTAL MEDICINE
    27. Goeckeritz, BE; Lees, A; Vos, Q; Tsokos, GC; Kuhlbusch, K; Mond, JJ
      Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350

      EUROPEAN JOURNAL OF IMMUNOLOGY
    28. Illges, H; Braun, M; Peter, HH; Melchers, I
      Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    29. Lackovic, G; Tomaskovic, M; Njari, B; Vrbanac, I; Krsnik, B; Rode, B; Valpotic, I
      Distribution of immune cells expressing CD3a, CD21 and S-100 protein markers in the porcine gut-associated lymphoid tissues

      EUROPEAN JOURNAL OF HISTOCHEMISTRY
    30. Ohtsubo, H; Arima, N; Tei, C
      Epstein-Barr virus involvement in T-cell malignancy: Significance in adultT-cell leukemia

      LEUKEMIA & LYMPHOMA
    31. Sato, S
      CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity

      JOURNAL OF DERMATOLOGICAL SCIENCE
    32. Omelyanenko, V; Kopeckova, P; Prakash, RK; Ebert, CD; Kopecek, J
      Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes

      PHARMACEUTICAL RESEARCH
    33. Tolnay, M; Vereshchagina, LA; Tsokos, GC
      Heterogeneous nuclear ribonucleoprotein DOE is a sequence-specific DNA-binding protein

      BIOCHEMICAL JOURNAL
    34. Prodinger, MW
      Complement receptor type two (CR2,CR21) - A target for influencing the humoral immune response and antigen-trapping

      IMMUNOLOGIC RESEARCH
    35. Young, AJ; Dudler, L; Yamaguchi, K; Marston, W; Hein, WR
      Structure and expression of ovine complement receptor type 2

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    36. Fremeaux-Bacchi, V; Kolb, JP; Rakotobe, S; Kazatchkine, MD; Fischer, EM
      Functional properties of soluble CD21

      IMMUNOPHARMACOLOGY
    37. Nakamura, S; Nagahama, M; Kagami, Y; Yatabe, Y; Takeuchi, T; Kojima, M; Motoori, T; Suzuki, R; Taji, H; Ogura, M; Mizoguchi, Y; Okamoto, M; Suzuki, H; Oyama, A; Seto, M; Morishima, Y; Koshikawa, T; Takahashi, T; Kurita, S; Suchi, T
      Hodgkin's disease expressing follicular dendritic cell marker CD21 withoutany other B-cell marker - A clinicopathologic study of nine cases

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    38. Chang, Y; Tung, CH; Huang, YT; Lu, J; Chen, JY; Tsai, CH
      Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes

      JOURNAL OF VIROLOGY
    39. Tacnet-Delorme, P; Boyer, V; Thielens, NM; Hernandez, JF; Bally, I; Sim, RB; Desgranges, C; Arlaud, GJ
      In vitro analysis of complement-dependent HIV-1 cell infection using a model system

      JOURNAL OF IMMUNOLOGY
    40. Jabs, WJ; Paulsen, M; Wagner, HJ; Kirchner, H; Kluter, H
      Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    41. Kamel, OW
      Unraveling the mystery of the lymphoid follicle

      AMERICAN JOURNAL OF PATHOLOGY
    42. FLEMING MD; SHAHSAFAEI A; DORFMAN DM
      ABSENCE OF DENDRITIC RETICULUM-CELL STAINING IS HELPFUL FOR DISTINGUISHING T-CELL-RICH B-CELL LYMPHOMA FROM LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE

      Applied immunohistochemistry
    43. FEARON DT
      THE COMPLEMENT-SYSTEM AND ADAPTIVE IMMUNITY

      Seminars in immunology
    44. GINALDI L; DEMARTINIS M; DOSTILIO A; MARINI L; QUAGLINO D
      CHANGES IN ANTIGEN EXPRESSION ON B-LYMPHOCYTES DURING HIV-INFECTION

      Pathobiology
    45. BRAUN M; MELCHERS I; PETER HH; ILLGES H
      HUMAN B-LYMPHOCYTES AND T-LYMPHOCYTES HAVE SIMILAR AMOUNTS OF CD21 MESSENGER-RNA, BUT DIFFER IN SURFACE EXPRESSION OF THE CD21 GLYCOPROTEIN

      International immunology (Print)
    46. FREMEAUXBACCHI V; FISCHER E; LECOANETHENCHOZ S; MANI JC; BONNEFOY JY; KAZATCHKINE MD
      SOLUBLE CD21 (SCD21) FORMS BIOLOGICALLY-ACTIVE COMPLEXES WITH CD23 - SCD21 IS PRESENT IN NORMAL PLASMA AS A COMPLEX WITH TRIMERIC CD23 AND INHIBITS SOLUBLE CD23-INDUCED IGE SYNTHESIS BY B-CELLS

      International immunology (Print)
    47. KHYATTI M; AHMAD A; BLAGDON M; FRADE R; MENEZES J
      BINDING OF THE ENDOGENOUSLY EXPRESSED EPSTEIN-BARR-VIRUS (EBV) ENVELOPE GLYCOPROTEIN GP350 WITH THE VIRAL RECEPTOR MASKS THE MAJOR EBV-NEUTRALIZING EPITOPE AND AFFECTS GP350-SPECIFIC ADCC

      Journal of leukocyte biology
    48. KIM YS; PAIK SR; KIM HK; YEOM BW; KIM I; LEE D
      EPSTEIN-BARR-VIRUS AND CD21 EXPRESSION IN GASTROINTESTINAL TUMORS

      Pathology research and practice
    49. Nichols, TC; Guthridge, JM; Karp, DR; Molina, H; Fletcher, DR; Holers, VM
      gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes

      EUROPEAN JOURNAL OF IMMUNOLOGY
    50. Fremeaux-Bacchi, V; Aubry, JP; Bonnefoy, JY; Kazatchkine, MD; Kolb, JP; Fischer, EM
      Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23

      EUROPEAN JOURNAL OF IMMUNOLOGY
    51. LING NR; HARDIE DL; JOHNSON GD; MACLENNAN ICM
      ORIGIN AND PROPERTIES OF SOLUBLE CD21 (CR-2) IN HUMAN BLOOD

      Clinical and experimental immunology
    52. SHUBINSKY G; SCHLESINGER M; POLLIACK A; RABINOWITZ R
      PATHWAYS CONTROLLING THE EXPRESSION OF SURFACE CD21 (CR-2) AND CD23 (FC(EPSILON)IIR) PROTEINS IN HUMAN-MALIGNANT B-CELLS

      Leukemia & lymphoma
    53. GAGRO A; DASIC G; SABIONCELLO A; RABATIC S; RECKZEH B; HAVEMANN K; KARDUM I; JAKSIC B; VITALE B
      PHENOTYPIC ANALYSIS OF RECEPTOR-LIGAND PAIRS ON B-CELLS IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia & lymphoma
    54. ARLIAN LG; RAPP CM; STEMMER BL; MORGAN MS; MOORE PF
      CHARACTERIZATION OF LYMPHOCYTE SUBTYPES IN SCABIETIC SKIN-LESIONS OF NAIVE AND SENSITIZED DOGS

      Veterinary parasitology
    55. OHTSUBO H; ARIMA N; MATSUSHITA K; HIDAKA S; FUJIWARA H; ARIMURA K; KUKITA T; FUKUMORI J; MATSUMOTO T; EIZURU Y; TANAKA H
      HUMAN-T-LYMPHOTROPIC-VIRUS-TYPE-I TAX INDUCTION OF CD21 EPSTEIN-BARR VIRUS RECEPTOR EXPRESSION ON T-CELLS AND ITS SIGNIFICANCE IN LEUKEMOGENESIS OF ADULT T-CELL LEUKEMIA/

      Experimental hematology
    56. KEARNSJONKER M; MONELLTORRENS E; ABBASI F; HOLERS VM; NOTKINS AL; SIGOUNAS G
      EBV BINDS TO LYMPHOCYTES OF TRANSGENIC MICE THAT EXPRESS THE HUMAN CR-2 GENE

      Virus research
    57. PRODINGER WM; SCHOCH J; SCHWENDINGER MG; HELLWAGE J; PARSON W; ZIPFEL PF; DIERICH MP
      EXPRESSION IN INSECT CELLS OF THE FUNCTIONAL DOMAIN OF CD21 (COMPLEMENT RECEPTOR-TYPE-2) AS A TRUNCATED SOLUBLE MOLECULE USING A BACULOVIRUS VECTOR

      Immunopharmacology
    58. ILLGES H; BRAUN M; PETER HH; MELCHERS I
      ANALYSIS OF THE HUMAN CD21 TRANSCRIPTION UNIT REVEALS DIFFERENTIAL SPLICING OF EXON-11 IN MATURE TRANSCRIPTS AND EXCLUDES ALTERNATIVE SPLICING AS THE MECHANISM CAUSING SOLUBILIZATION OF CD21

      Molecular immunology
    59. TOLNAY M; LAMBRIS JD; TSOKOS GC
      TRANSCRIPTIONAL REGULATION OF THE COMPLEMENT RECEPTOR-2 GENE - ROLE OF A HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN

      The Journal of immunology
    60. XU YY; VOLANAKIS JE
      CONTRIBUTION OF THE COMPLEMENT CONTROL PROTEIN MODULES OF C2 IN C4B BINDING ASSESSED BY ANALYSIS OF C2 FACTOR-B CHIMERAS/

      The Journal of immunology
    61. SCHWENDINGER MG; SPRUTH M; SCHOCH J; DIERICH MP; PRODINGER WM
      A NOVEL MECHANISM OF ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION ACCOUNTS FOR THE DEPOSITION OF C3 FRAGMENTS ON CR-2-EXPRESSING HOMOLOGOUS CELLS

      The Journal of immunology
    62. OLIVER AM; MARTIN F; GARTLAND GL; CARTER RH; KEARNEY JF
      MARGINAL ZONE B-CELLS EXHIBIT UNIQUE ACTIVATION, PROLIFERATIVE AND IMMUNOGLOBULIN SECRETORY RESPONSES

      European Journal of Immunology
    63. RELJIC R; COSENTINO G; GOULD HJ
      FUNCTION OF CD23 IN THE RESPONSE OF HUMAN B-CELLS TO ANTIGEN

      European Journal of Immunology
    64. GHADERI AA; DOROUDCHI M; EMAD M; AMIN R
      ELEVATION OF CD21 AND CD23 POSITIVE LYMPHOCYTES IN CHILDREN WITH ATOPIC-DERMATITIS

      EJD. European journal of dermatology
    65. ILLGES H; BRAUN M; PETER HH; MELCHERS I
      A PLASMID FOR THE QUANTIFICATION OF THE CD21 HUMAN INTERFERON-ALPHA RECEPTOR EXPRESSION BY PCR

      European cytokine network
    66. BONNEFOY JY; GAUCHAT JF; LIFE P; GRABER P; MAZZEI G; AUBRY JP
      PAIRS OF SURFACE MOLECULES INVOLVED IN HUMAN IGE REGULATION - CD23-CD21 AND CD40-CD40L

      The European respiratory journal
    67. LLOPIS MJP; HARMS G; HARDONK MJ; TIMENS W
      HUMAN IMMUNE-RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDES - COMPLEMENT-MEDIATED LOCALIZATION PREFERENTIALLY ON CD21-POSITIVE SPLENIC MARGINAL ZONE B-CELLS AND FOLLICULAR DENDRITIC CELLS

      Journal of allergy and clinical immunology
    68. MOLINA H; HOLERS VM; LI B; FANG YF; MARIATHASAN S; GOELLNER J; STRAUSSSCHOENBERGER J; KARR RW; CHAPLIN DD
      MARKEDLY IMPAIRED HUMORAL IMMUNE-RESPONSE IN MICE DEFICIENT IN COMPLEMENT RECEPTOR-1 AND RECEPTOR-2

      Proceedings of the National Academy of Sciences of the United Statesof America
    69. PRODINGER WM; LARCHER C; SCHWENDINGER M; DIERICH MP
      LIGATION OF THE FUNCTIONAL DOMAIN OF COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) IS RELEVANT FOR COMPLEX-FORMATION IN T-CELL LINES

      The Journal of immunology
    70. GASQUE P; CHAN P; MAUGER C; SCHOUFT MT; SINGHRAO S; DIERICH MP; MORGAN BP; FONTAINE M
      IDENTIFICATION AND CHARACTERIZATION OF COMPLEMENT C3 RECEPTORS ON HUMAN ASTROCYTES

      The Journal of immunology
    71. HENCHOZLECOANET S; JEANNIN P; AUBRY JP; GRABER P; BRADSHAW CG; POCHON S; BONNEFOY JY
      THE EPSTEIN-BARR VIRUS-BINDING SITE ON CD21 IS INVOLVED IN CD23 BINDING AND INTERLEUKIN-4-INDUCED IGE AND IGG4 PRODUCTION BY HUMAN B-CELLS

      Immunology
    72. LEGENDRE C; GRAS G; KRZYSIEK R; GALANAUD P; RICHARD Y; DORMONT D
      MECHANISMS OF OPSONIZED HIV ENTRY IN NORMAL B-LYMPHOCYTES

      FEBS letters
    73. AXCRONA K; GRAY D; LEANDERSON T
      REGULATION OF B-CELL GROWTH AND DIFFERENTIATION VIA CD21 AND CD40

      European Journal of Immunology
    74. FREMEAUXBACCHI V; BERNARD I; MAILLET F; MANI JC; FONTAINE M; BONNEFOY JY; KAZATCHKINE MD; FISCHER E
      HUMAN LYMPHOCYTE SHED A SOLUBLE FORM OF CD21 (THE C3DG EPSTEIN-BARR VIRUS RECEPTOR, CR-2) THAT BINDS IC3B AND CD23/

      European Journal of Immunology
    75. THORNTON BP; VETVICKA V; ROSS GD
      FUNCTION OF C3 IN A HUMORAL RESPONSE - IC3B C3DG BOUND TO AN IMMUNE-COMPLEX GENERATED WITH NATURAL ANTIBODY AND A PRIMARY ANTIGEN PROMOTES ANTIGEN UPTAKE AND THE EXPRESSION OF COSTIMULATORY MOLECULES BY ALL B-CELLS, BUT ONLY STIMULATES IMMUNOGLOBULIN-SYNTHESIS BY ANTIGEN-SPECIFIC B-CELLS/

      Clinical and experimental immunology
    76. JAGER M; PRANG N; MITTERER M; LARCHER C; HUEMER HP; REISCHL U; WOLF H; SCHWARZMANN F
      PATHOGENESIS OF CHRONIC EPSTEIN-BARR-VIRUS INFECTION - DETECTION OF AVIRUS-STRAIN WITH A HIGH-RATE OF LYTIC REPLICATION

      British Journal of Haematology
    77. WICKHAM TJ; SHULER ML; HAMMER DA
      A SIMPLE-MODEL TO PREDICT THE EFFECTIVENESS OF MOLECULES THAT BLOCK ATTACHMENT OF HUMAN RHINOVIRUSES AND OTHER VIRUSES

      Biotechnology progress
    78. BONNEFOY JY; GAUCHAT JF; LIFE P; GRABER P; AUBRY JP; LECOANETHENCHOZ S
      REGULATION OF IGE SYNTHESIS BY CD23 CD21 INTERACTION/

      International archives of allergy and immunology
    79. GAGRO A; RABATIC S; LOKARKOLBAS R; MEDARLASIC M; ZIMIC L
      EFFECT OF AN ASTHMATIC ATTACK ON CD23 AND CD21 EXPRESSION ON LYMPHOCYTES FROM ALLERGIC CHILDREN DURING THE ALLERGEN SEASON

      Clinical and experimental allergy
    80. FEARON DT; CARTER RH
      THE CD19 CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY/

      Annual review of immunology
    81. SEYA T
      HUMAN REGULATOR OF COMPLEMENT ACTIVATION (RCA) GENE FAMILY PROTEINS AND THEIR RELATIONSHIP TO MICROBIAL INFECTION

      Microbiology and immunology
    82. MATHEW JM; NAZIRUDDIN B; DUFFY B; KRYCH M; MOHANAKUMAR T
      FUNCTIONAL-ANALYSIS OF COMPLEMENT RECEPTOR-1 USING A NEW MONOCLONAL-ANTIBODY, KUN241

      Hybridoma
    83. YOSHIYAMA H; SHIMIZU N; TAKADA K
      PERSISTENT EPSTEIN-BARR-VIRUS INFECTION IN A HUMAN T-CELL LINE - UNIQUE PROGRAM OF LATENT VIRUS EXPRESSION

      EMBO journal
    84. RODGAARD A; THOMSEN BS; BENDIXEN G; BENDTZEN K
      INCREASED EXPRESSION OF COMPLEMENT RECEPTOR-TYPE-1 (CR1,CD35) ON HUMAN PERIPHERAL-BLOOD T-LYMPHOCYTES AFTER POLYCLONAL ACTIVATION IN-VITRO

      Immunologic research
    85. LARCHER C; JULEN N; PRODINGER WM; TOTSCH M; GURTLER L; DIERICH MP
      REDUCED CD21(CR2) AND CD54 (ICAM-1) EXPRESSION IN MT2 CELLS WITH HIV-1 OR HIV-2 STRAINS

      Immunology letters
    86. LUND O; HANSEN J; SORENSEN AM; MOSEKILDE E; NIELSEN JO; HANSEN JES
      INCREASED ADHESION AS A MECHANISM OF ANTIBODY-DEPENDENT AND ANTIBODY-INDEPENDENT COMPLEMENT-MEDIATED ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Journal of virology
    87. JIMENEZCLAVERO MA; GONZALEZRUBIO C; LARRUCEA S; GAMALLO C; FONTAN G; LOPEZTRASCASA M
      CELL-SURFACE MOLECULES RELATED TO FACTOR-J IN HUMAN LYMPHOID-CELLS AND CELL-LINES

      The Journal of immunology
    88. BARTLETT WC; KELLY AE; JOHNSON CM; CONRAD DH
      ANALYSIS OF MURINE SOLUBLE FC-EPSILON-RII SITES OF CLEAVAGE AND REQUIREMENTS FOR DUAL-AFFINITY INTERACTION WITH IGE

      The Journal of immunology
    89. MOLINA H; PERKINS SJ; GUTHRIDGE J; GORKA J; KINOSHITA T; HOLERS VM
      CHARACTERIZATION OF A COMPLEMENT RECEPTOR-2 (CR2, CD21) LIGAND-BINDING SITE FOR C3 - AN INITIAL MODEL OF LIGAND INTERACTION WITH 2 LINKED SHORT CONSENSUS REPEAT MODULES

      The Journal of immunology
    90. LARCHER C; KEMPKES B; KREMMER E; PRODINGER WM; PAWLITA M; BORNKAMM GW; DIERICH MP
      EXPRESSION OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2) INDUCES CD21 CR2 ON B-CELL AND T-CELL LINES AND SHEDDING OF SOLUBLE CD21/

      European Journal of Immunology
    91. BROWN MH; PRESTON S; BARCLAY AN
      A SENSITIVE ASSAY FOR DETECTING LOW-AFFINITY INTERACTIONS AT THE CELL-SURFACE REVEALS NO ADDITIONAL LIGANDS FOR THE ADHESION PAIR RAT CD2 AND CD48

      European Journal of Immunology
    92. KANEKO T; FUKUDA J; YOSHIHARA T; ZHENG H; MORI S; MIZOGUCHI H; OSHIMI K
      NASAL NATURAL-KILLER (NK) CELL LYMPHOMA - REPORT OF A CASE WITH ACTIVATED NK CELLS CONTAINING EPSTEIN-BARR-VIRUS AND EXPRESSING CD21 ANTIGEN, AND COMPARATIVE-STUDIES OF THEIR PHENOTYPE AND CYTOTOXICITY WITH NORMAL NK CELLS

      British Journal of Haematology
    93. LARCHER C; FEND F; MITTERER M; PRANG N; SCHWARZMANN F; HUEMER HP
      ROLE OF EPSTEIN-BARR-VIRUS AND SOLUBLE CD21 IN PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS

      British Journal of Haematology
    94. CAMBIER JC; PLEIMAN CM; CLARK MR
      SIGNAL-TRANSDUCTION BY THE B-CELL ANTIGEN RECEPTOR AND ITS CORECEPTORS

      Annual review of immunology
    95. TATSUMI E; YONEDA N; KAWANO S; YAMAGUCHI N
      CD21 ANTIGEN IN T-LINEAGE NEOPLASTIC LYMPHOID-CELLS - CHARACTERISTIC EXPRESSION AT THYMIC STAGE

      American journal of hematology
    96. PULCZYNSKI S; BOESEN AM; JENSEN OM
      MODULATION AND INTRACELLULAR-TRANSPORT OF CD20 AND CD21 ANTIGENS INDUCED BY B1 AND B2 MONOCLONAL-ANTIBODIES IN RAJI AND JOK-1 CELLS - AN IMMUNOFLUORESCENCE AND IMMUNOELECTRON MICROSCOPY STUDY

      Leukemia research
    97. MARTIN DR; MARLOWE RL; AHEARN JM
      DETERMINATION OF THE ROLE FOR CD21 DURING EPSTEIN-BARR-VIRUS INFECTION OF B-LYMPHOBLASTOID CELLS

      Journal of virology
    98. MONTEFIORI DC; GRAHAM BS; ZHOU JY; ZHOU JT; AHEARN JM
      BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO THE C3B C4B RECEPTOR CR-1 (CD35) AND RED-BLOOD-CELLS IN THE PRESENCE OF ENVELOPE-SPECIFICANTIBODIES AND COMPLEMENT/

      The Journal of infectious diseases
    99. MOLINA H; KINOSHITA T; WEBSTER CB; HOLERS VM
      ANALYSIS OF C3B C3D BINDING-SITES AND FACTOR-I COFACTOR REGIONS WITHIN MOUSE COMPLEMENT RECEPTOR-1 AND RECEPTOR-2/

      The Journal of immunology
    100. AUBRY JP; POCHON S; GAUCHAT JF; NUEDAMARIN A; HOLERS VM; GRABER P; SIEGFRIED C; BONNEFOY JY
      CD23 INTERACTS WITH A NEW FUNCTIONAL EXTRACYTOPLASMIC DOMAIN INVOLVING N-LINKED OLIGOSACCHARIDES ON CD21

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 13:19:25